Raymond James Financial
PRCT icon

Raymond James Financial’s Procept Biorobotics PRCT Stock Holding History

Raymond James Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Buy
+15,321
New +$384K ﹤0.01% 4743
2025
Q3 		– Sell
-4,985
Closed -$287K – 6290
2025
Q2 		$287K Sell
4,985
-492
-9% -$27.8K ﹤0.01% 4312
2025
Q1 		$319K Sell
5,477
-14,976
-73% -$1.02M ﹤0.01% 4191
2024
Q4 		$1.65M Buy
+20,453
New +$1.75M ﹤0.01% 3106

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Raymond James Financial's PRCT Position: Q2 2026 in Review

Raymond James Financial opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 15,321 shares worth $346K. The stake represents ﹤0.01% of the portfolio and ranks #4743 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in PRCT as recently as Q2 2025.

Raymond James Financial first reported a position in PRCT in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.65M in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Raymond James Financial held 15,321 shares of Procept Biorobotics worth $346K as of Q2 2026.
  • Procept Biorobotics was a new Raymond James Financial position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4743 holding.
  • Raymond James Financial first reported a position in Procept Biorobotics in Q4 2024 and has held it in 4 quarters since.
  • Raymond James Financial's Procept Biorobotics position peaked at $1.65M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.